Christopher S Francklyn (Christopher Francklyn)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

High Throughput

Chemotherapy Induced

Cell Cycle Arrest

Atomic Force Microscopy

Top Venues

RSC chemical biology

ACS chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Sibyl F D Batey, Melissa J Davie, Edward S Hems, Jonathon D Liston, Thomas A Scott, Silke Alt, Christopher S Francklyn, Barrie Wilkinson
The catechol moiety of obafluorin is essential for antibacterial activity. RSC chemical biology 4 (11) (2023)
Patrick Mullen, Jamie A Abbott, Theresa Wellman, Mahafuza Aktar, Christian Fjeld, Borries Demeler, Alicia M Ebert, Christopher S Francklyn
Neuropathy-associated histidyl-tRNA synthetase variants attenuate protein synthesis in vitro and disrupt axon outgrowth in developing zebrafish. The FEBS journal 288 (1) (2020)
Thomas A Scott, Sibyl F D Batey, Patrick Wiencek, Govind Chandra, Silke Alt, Christopher S Francklyn, Barrie Wilkinson
Immunity-Guided Identification of Threonyl-tRNA Synthetase as the Molecular Target of Obafluorin, a β-Lactone Antibiotic. ACS chemical biology 14 (12) (2019)
Christopher S Francklyn, Herve Roy, Rebecca Alexander
11th IUBMB Focused Meeting on the Aminoacyl-tRNA Synthetases: Sailing a New Sea of Complex Functions in Human Biology and Disease. Biomolecules 8 (2) (2018)
Jamie A Abbott, Rebecca Meyer-Schuman, Vincenzo Lupo, Shawna Feely, Inès Mademan, Stephanie N Oprescu, Laurie B Griffin, M Antonia Alberti, Carlos Casasnovas, Sharon Aharoni, Lina Basel-Vanagaite, Stephan Züchner, Peter De Jonghe, Jonathan Baets, Michael E Shy, Carmen Espinós, Borries Demeler, Anthony Antonellis, Christopher S Francklyn
Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy. Human mutation 39 (3) (2017)